Integrum has been granted a registered trademark for OPRA® Implant System in the EU

Mölndal, Sweden - May 15, 2024 -Integrum (publ) (Nasdaq First North Growth Marketing: INTEG B) announces that the European Union Intellectual Property Office, EUIPO, has approved Integrum's product registration application for the OPRA® Implant System.

Until now, the OPRA® Implant system has been an unregistered mark without legal protection.

As it is granted a registered trademark, Integrum now obtains unitary immaterial protection for the product in the entire territory of the EU.

"We are very pleased to have obtained a registered trademark for OPRA® as it grants us legal protection of the trademark in all EU countries, and we see it as another recognition of our unique offer," says Rickard Brånemark, CEO of Integrum.

For more information, please contact:
Rickard Brånemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: rickard.branemark@integrum.se

Jörgen Svanström, CFO
Phone: + 46 (0) 70 734 96 60
E-mail: Jorgen.svanstrom@integrum.se

Certified Adviser

Carnegie Investment Bank AB (publ) is Certified Adviser.

About integrum

Integrum AB is a publicly traded company (INTEG B: Nasdaq First North Growth Market) based outside of Gothenburg, Sweden, with a U.S. subsidiary in San Francisco. Since 1990, its OPRA™ Implant System has helped improve the quality of life for hundreds of people who are amputees by directly attaching a prosthesis to the bone and musculoskeletal system, therefore avoiding the need for a socket. Based on osseointegration, the bone-anchored implant system offers a range of benefits, including improved mobility and function, enhanced comfort, reduced pressure, a stable attachment and more. The OPRA™ Implant System was approved by the U.S. Food and Drug Administration (FDA) in 2020 and is the only FDA-approved bone-anchored implant system specifically designed for use in amputees available in the U.S. Today, Integrum continues to perform research and develop custom-made medical device solutions in close collaboration with scientists and clinicians. To learn more, please visit https://integrum.se/. 

https://news.cision.com/integrum-ab/r/integrum-has-been-granted-a-registered-trademark-for-opra--implant-system-in-the-eu,c3980250

https://mb.cision.com/Public/17531/3980250/ada73da6a47b9aba.pdf

(c) 2024 Cision. All rights reserved., source Press Releases - English